Biotech CEO Jeff Galvin Explains Cell and Gene Therapy to Stony Brook Biomedical Engineering Society
Вставка
- Опубліковано 20 жов 2024
- Jeff Galvin, CEO of American Gene Technologies (AGT), gives an inspiring talk at the Stony Brook University Biomedical Engineering Society (BMES) detailing his journey from working closely with computers in Silicon Valley to leveraging the progression of gene and cell therapy for curing major diseases after meeting Roscoe Brady. Galvin credits a discussion with Brady about viral vectors as his inspiration for seeking opportunities to rewrite cells, which he refers to as the “human computers” of the human body, using gene programming and biotech.
In this educational talk, Galvin discusses AGT’s groundbreaking entrance into the first phase of clinical trials toward HIV treatment using gene therapy. He details an ever-increasing ability to edit genes with viral vectors and CRISPR through a continued understanding of system biology and genetics. He refers to Moore’s Law to describe the technological capability in the industry doubling every year, while the cost of technology halves, resulting in limitless possibilities for efficient and valuable solutions for humankind.
Topics covered in this video include: Stony Brook BMES, Biomedical Engineering, Stony Brook University, Biotech, CEO, gene and cell therapy, viral vectors, CRISPR, educational talk, inspiring talk, HIV, gene programming, technology
-------
About AGT:
American Gene Technologies (AGT) is a gene and cell therapy company with a proprietary gene-delivery platform for rapid development of cell and gene therapies to cure infectious diseases, cancers, and inherited disorders. AGT's mission is to transform people's lives through genetic medicines that rid the body of disease. Keep up to date on our Covid19 Lab 2021.
Visit our website and subscribe to our news for updates here: www.americange...
Subscribe to receive our news updates here:
bit.ly/3ughPNR
Follow the company on social media---
Twitter:
Jeff - @jeffreygalvin - / jeffreygalvin
AGT - @americangene - / americangene
LinkedIn:
Jeff - / jeff-galvin-60258
AGT - / american-gene-technolo...
Facebook/Instagram:
Facebook - / amerigene
Instagram - / americangenetechnologies
God Bless you Jeff - Thank you for giving us hope
The possibility of combining AGT103-T and EBT-101 Therapies:
In combining EBT-101 and AGT103-T, the patient would first take the gene and cell therapy treatment, AGT103-T, which involves HIV-specific CD4 T-cells that are genetically modified to resist HIV, by having a sample of peripheral blood cells collected from the patient and CD4 cells that recognize HIV’s Gag protein. A harmless lentivirus vector is then used to insert genes that disable CCR5 receptors, where HIV uses to enter cells. The modified CD4 cells are then multiplied and returned into the patient’s body.
The same patient would then take the CRISPR-based one-time gene therapy, EBT-101, that will utilize AAV to deliver an intravenous infusion intended to functionally cure the HIV infection. The CRISPR cuts out or excise the HIV that has wrapped around the DNA cells. This therapy would harness the AAV at a relatively low dose to deliver the treatment, which would deploy CRISPR-Cas9 and two guide RNAs that target three sites within the HIV genome.
Can two functional cures in AGT103-T and EBT-101 combine into one EBT-101 + AGT103-T sterilizing cure?
Cure from hiv possible in which year please save from hiv
Jeff God bless your work ....I have been sending you message pls I want to have a chat with you if you don't mind
Hi jeff galvin everyone curiously waiting for your success, by God grace you will be a torchbearer and your name echoes as long as sun will arise.
Jeff, thank you for interesting story
Thank you so much for your comment.
Thanks you American science Tys God bless you
@@AmericanGeneTechnologies
Has American Gene Technologies thought about contacting and combining research with Excision Bio-Therapeutics (developers of EBT-101), which AGT103-T + EBT-101 can be merged into one treatment?
With AGT103-T, the HIV therapeutic cure is a genetically modified cell product made from a person's own cells and EBT-101 is a therapeutic HIV cure using CRISPR-Cas9 & dual guide RNA as a therapy to eradicate HIV. EBT-101 is also in clinical trials.
May Archangel Rsphael enlighten you with the Green Light of Higher knowledge.
Amen
Amen. I can tell you are Catholic 😉
. How great it would be to have a cure for cancer. Especially ovarian and lung cancer.
I have a quest that when do hiv cure be available in market
In 2025
AGT is working to facilitate the fastest possible progression of AGT103-T, but it is not possible to predict availability yet. For more information: www.knowledgebase.americangene.com/when-will-agt103-t-be-available-for-use
How long till cancer vaccine ?
how do we invest in your company???
Hii sir, by which yr we expect a permanent cure for hiv
The answer is 2021. AGT is on the cusp. Vaccines will follow.
AGT is working to facilitate the fastest possible progression of AGT103-T, but it is not possible to predict availability yet. For more information: www.knowledgebase.americangene.com/when-will-agt103-t-be-available-for-use
I would love to follow up on your progress, what are the avenues
To stay up to date, connect with us on social media or visit our web site and sign up for our newsletter. For more information:www.knowledgebase.americangene.com/how-can-people-from-africa-participate-in-the-trials
Parabéns que tudo está dando certo # Deus abençoe a América...
Oh oh Jehoval God bless you
Thank you so much Beda Mapunda. We cherish your positive blessings.
Next you need to fix the liver so it can start synthesizing our own vitamin C
Sounds like the idea used for covid vaccine. Interesting.
do it fast people live in the world will consider you first great hospital in USA and your country will get power of,love from people poor ,and make it before some country make first then u